Bruker Co. (BRKR) to Issue Quarterly Dividend of $0.05 on September 16th

Bruker Co. (NASDAQ:BRKR) announced a quarterly dividend on Monday, August 12th, Wall Street Journal reports. Shareholders of record on Monday, September 2nd will be given a dividend of 0.05 per share by the medical research company on Monday, September 16th. This represents a $0.20 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date is Friday, August 30th.

Bruker has raised its dividend payment by an average of 7.7% annually over the last three years. Bruker has a payout ratio of 6.6% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Bruker to earn $3.14 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.4%.

Bruker Trading Down 0.2 %

BRKR traded down $0.11 during trading on Wednesday, reaching $61.26. 245,926 shares of the company’s stock were exchanged, compared to its average volume of 1,026,318. Bruker has a one year low of $53.79 and a one year high of $94.86. The company has a current ratio of 1.81, a quick ratio of 0.91 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $8.90 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 2.39 and a beta of 1.20. The firm has a fifty day moving average price of $64.10 and a two-hundred day moving average price of $75.48.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, meeting analysts’ consensus estimates of $0.52. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The company had revenue of $800.70 million for the quarter, compared to analyst estimates of $799.44 million. During the same period in the prior year, the firm posted $0.50 EPS. The company’s quarterly revenue was up 17.4% on a year-over-year basis. As a group, equities research analysts forecast that Bruker will post 2.66 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on BRKR shares. Citigroup reduced their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. TD Cowen dropped their target price on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research report on Wednesday, August 7th. Jefferies Financial Group started coverage on shares of Bruker in a research report on Monday, June 3rd. They set a “buy” rating and a $85.00 target price on the stock. Stifel Nicolaus dropped their target price on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a research report on Monday, May 20th. Finally, The Goldman Sachs Group dropped their target price on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research report on Tuesday, July 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $80.80.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.